Skip to main content
Log in

Transdermal Delivery of Fentanyl by Electroporation II. Mechanisms Involved in Drug Transport

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of the present report was to systematically analyze the mechanisms involved in fentanyl transdermal transport by skin electroporation.

Methods. The study was performed in vitro with full-thickness hairless rat skin, skin electroporation being carried out with five exponentially-decaying pulses of 100 V applied voltage and around 600 ms pulse duration.

Results. Transport during and after pulsing are both important in transdermal delivery of fentanyl by skin electroporation. Rapid transport occurred during pulsing due to electrophoresis and diffusion through highly permeabilized skin. No electroosmosis was observed. The slow post-pulse passive transport was explained by lasting changes in skin permeability. Measurements of fentanyl quantities in the skin demonstrated that pulses rapidly loaded the viable part of the skin with fentanyl and hence rapidly overcame skin barrier.

Conclusions. The different contributions of the transport mechanisms appear to depend on the physicochemical parameters of the transported molecule as well as the solution, suggesting that mechanistic analysis and careful consideration of formulation variables are essential for the development and optimization of drug delivery by skin electroporation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. J. Hadgraft, and R. H Guy (Eds), Transdermal Drug Delivery: Developmental Issues and Research Initiatives, Marcel Dekker Inc (1989).

  2. S. D. Roy and G. L. Flynn. Transdermal delivery of narcotic analgesics: pH, anatomical and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm. Res. 7:842–847 (1990).

    Google Scholar 

  3. J. R. Varvel, S. L. Shafer, S. S. Hwang, P. A. Coen, and D. R. Stanski. Absorption characteristics of transdermally administered fentanyl. Anethesiology 70:928–934 (1989).

    Google Scholar 

  4. M. R. Prausnitz, V. G. Bose, R. Langer, and J. C. Weaver. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA 90:10504–10508 (1993).

    Google Scholar 

  5. R. Vanbever, N. Lecouturier, and V. Préat. Transdermal delivery of metoprolol by electroporation. Pharm. Res. 11:1657–1662 (1994).

    Google Scholar 

  6. R. Vanbever and V. Préat. Factors affecting transdermal delivery of metoprolol by Electroporation. Bioelectrochem. Bioenerget. 38:223–228 (1995).

    Google Scholar 

  7. V. Préat and R. Vanbever. Transdermal drug delivery by electroporation, in Prediction of Percutaneous Penetration, vol 4 (in press).

  8. U. Pliquett and J. C. Weaver. Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and the passive electrical properties. Bioelectrochem. Bioenerget. 39:1–12 (1996).

    Google Scholar 

  9. R. Vanbever, E. Le Boulengé, and V. Préat. Transdermal delivery of fentanyl by electroporation I. Influence of Electrical factors. Pharm. Res. 13:559–565 (1996).

    Google Scholar 

  10. D. B. Bommannan, J. Tamada, L. Leung, and R. O. Potts. Effect of electroporation on transdermal iontophoretic delivery of Luteinizing Hormone (LHRH) in vitro. Pharm. Res. 11:1809–1814 (1994).

    Google Scholar 

  11. T. Zewert, U. Pliquett, R. Langer, and J. C. Weaver. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Acta 2122:286–292 (1995).

    Google Scholar 

  12. M. R. Prausnitz, E. R. Edelman, J. A. Gimm, R. Langer, and J. C. Weaver. Transdermal delivery of heparin by skin electroporation. Biotechnology 13:1205–1209 (1995).

    Google Scholar 

  13. D. Chang, B. Chassy, J. Saunders, A. Sowers (Eds). Guide to Electroporation and Electrofusion, Academic Press Inc. (1992).

  14. H. Schaefer and E. Lamaud. Standardization of experimental models, In Schott, B and Schaefer H. (Eds), Pharmacology of Skin, 1:77–80 (1987).

  15. A. Jadoul, C. Hanchard, S. Thysman, V. Préat. Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int J. Pharm. 120:221–228 (1995).

    Google Scholar 

  16. R. Guy (Ed) Iontophoresis Adv. Drug Delivery Rev. 9:119–317 (1992).

  17. S. Thysman, V. Préat, and M. Roland. Factors affecting iontophoretic mobility of metoprolol. J. Pharm. Sci. 81:670–675 (1992).

    Google Scholar 

  18. S. Thysman, C. Tasset, and V. Préat. Transdermal iontophoresis of fentanyl: delivery and mechanistic analysis. Int. J. Pharm. 101:105–113 (1994).

    Google Scholar 

  19. M. B. Delgado-Charro, A. M. Rodriguez-Bayon, R. H. Guy. Iontophoresis of nafarelin: effects of current density and concentration on electrotransport in vitro. J. Controlled Release 35:35–40 (1995).

    Google Scholar 

  20. R. Vanbever, M.-A. Leroy, and V. Préat. Transdermal permeation of neutral molecules by electroporation (in preparation).

  21. R. Vanbever, G. Langers, and V. Préat. Rapid onset of action of fentanyl delivered in vivo by skin electroporation (in preparation).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanbever, R., De Morre, N. & Préat, V. Transdermal Delivery of Fentanyl by Electroporation II. Mechanisms Involved in Drug Transport. Pharm Res 13, 1360–1366 (1996). https://doi.org/10.1023/A:1016073917125

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016073917125

Navigation